Lates News
According to AI news, Open Source Securities issued a research report on August 21, giving a buy rating to Huadong Medicine (000963.SZ). The rating reasons mainly include: 1) rapid growth in sales of innovative drugs, and continuous establishment of product matrix; 2) "pharma valuation reshaping" represents the company, accelerating innovation and transformation. (Daily Economic News)
Latest